RVMD FDA approves RASONQUE for metastatic pancreatic cancer
RVMD says the FDA approved RASONQUE, a targeted RAS inhibitor for metastatic pancreatic cancer, and it is now available in the U.S.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.